Clinical Trial Data on Low-Dose Dapoxetine Efficacy

2H2O and a pH of 5.5 were also added (Cheng et al.

Ex vivo permeability study

Lastly, the primary emulsion was homogenized at 13,500 rpm for 10 min while being drizzled onto the aqueous external phase at a constant rate until the formation of w/o/w. The EE% of DH-loaded PLGA NPs was indirectly estimated by subtracting the free DH (non-entrapped drug) from the total amount of DH that was actually added to the formulation. At 4 °C, the NPs were subjected to a cooling centrifugation (SIGMA 3–30 K, Steinheim, Germany) at 14,000 rpm for 1.5 h (Ahmed et al. The concentration of residual free DH in the filtrate was determined spectrophotometrically at λmax 292 nm after an appropriate dilution. The equation below was employed to estimate the EE% of the DH NPs (1). The rotation speed was modified to 100 rpm, and the temperature was set to 32 ± 0.5 °C during the release research. To ensure a consistent volume, 3 ml aliquots were removed from the release medium and replaced with an equivalent volume of fresh medium at 0.5, 1, 2, 3, 4, 6, and 8 h later. The concentration of DH was determined by spectrophotometry at λmax 292 nm following the filtration of samples using a 0.45 m Millipore filter. The results of the release research were presented as means ± standard deviations for each formulation, and they were conducted in triplicate. The cumulative percentage of DH-loaded PLGA NPs that were emitted was plotted against time. The mechanism of DH release from its PLGA NPs was determined by fitting the acquired data to zero-order, first-order kinetics, and the Higuchi diffusion model. The orders of release were subsequently established by determining the magnitude of the coefficients of determination (R2) in each instance and subsequently selecting the appropriate mathematical model. The local Animal Ethics Committee of Nahda University approved this investigation. Camel buccal mucosa was obtained from a nearby slaughterhouse and utilized within one hour of the animal’s death. Distilled water was used to collect the nasal mucosa of the camel that had been recently removed, with the exception of the septum (El-Nabarawi et al. For 30–60 min, the membrane was equilibrated in distilled water (El-Nabarawi et al. The nasal membrane was recognized, and the superior nasal concha was subsequently isolated. The vertical Franz diffusion cell was then used to place the superior nasal membrane that had been excised. A Franz diffusion cell with a surface area of 5 cm2 was employed for ex vivo diffusion investigations.

Quick Tips

The average NP size (z-ave), polydispersity index (PDI), and zeta potential of DH-PLGA-NP were evaluated using dynamic light scattering (DLS) in a Nano ZS Zetasizer (Malvern Instruments, Malvern, UK). Before the measurement, each sample was attenuated by the addition of deionized water. The analysis was conducted at ambient temperature (25 ± 2 °C). The mean values ± SD were determined by scanning each specimen three times. An in vitro discharge study was conducted in triplicate at 32 ℃ across a cellulose dialysis membrane. The nasal membrane surface was only briefly flooded with the diffusion fluid by maintaining the temperature of the chamber, which contained 100 ml of distilled water, at 37 ± 0.5 °C and agitating continuously with a magnetic bar at 100 rpm. The investigation was conducted in non-occlusive conditions. Various volumes of PLGA NP dispersion containing constant quantities of DH (3 mg) were introduced into the donor compartment of the Franz diffusion cell. At predetermined intervals (1, 2, 3, 4, 5, 6, 8, 12, and 24 h), no more than 3 ml of receptor compartment samples were extracted and replaced with equivalent volumes of new milieu. Lastly, the samples were analysed at 292 nm using a spectrophotometer after being filtered through a 0.45-m Millipore filter. The total quantity of DH penetrated per unit area (g/cm2) was plotted against time (h) for each formulation. For each DH-PLGA-NP and the control DH solution, the permeation parameters Q24 in g/cm2, latency time in minutes, permeability coefficient (Kp) in cm/h, and drug flux (Jss) in g/cm2 h were determined.

5. What should I know while taking PRILIGY?

In summary, various formulations of PLGA nanoparticles (equivalent to 3 mg of DH) (Salem et al. 2020b) and glass cylinders (6 cm in length and 2.5 cm in internal diameter) were introduced and sealed at one end with a dialysis membrane with a molecular weight cutoff of 12,000 Da. Overnight, the membrane was submerged in the receptor milieu. The laden cylinders were secured using the shafts of the USP dissolution tester apparatus (Abdelrahman et al. Thirty milliliters of simulated nasal electrolyte solution (SNES) with a pH of 5.5 were employed as the release medium to ensure sink conditions (Aboelwafa et al. Additionally, the following formula was employed to calculate the enhancement index (EI) (El-Nabarawi et al. The optimized DH-PLGA-NP was subjected to a morphological investigation using a JEM-1400 transmission electron microscope (Jeol, Tokyo, Japan). A drop of the Nano dispersion was deposited on a copper grid after it had been adequately diluted, and the excess was removed using filter paper. Afterward, a negative stain was applied, which was a 2% w/v phosphotungstic acid aqueous solution. The air-dried sample was subsequently investigated using a transmission electron microscope at 80 kV at room temperature (Abdullah et al. The sealed containers at 4 °C were used to retain the optimal DH-loaded PLGA NPs formulation for a period of 3 months. Samples of the optimized DH-prepared nanoformula mounted on PLGA NPs were extracted immediately following assembly and at predetermined intervals for a period of 3 months. The zeta potential, entrapment, PDI, and particle diameter of the samples were examined (Nasr et al. The thermal characteristics of unadulterated DH, PLGA, PVA, and span 80, as well as (1:1) mixtures of each of these substances with DH, were assessed using DSC (DSC 50 Shimadzu, Kyoto, Japan).

PrEP (HIV Pre-Exposure Prophilaxis)

The following ingredients were used to produce a variety of PLGA NPs for DH: PLGA (25, 50, and 75 mg), PVA (1, 1.5, and 2% w/v), and aqueous internal phase volume (0.5, 0.75, and 1 ml) (Abdelkader et al. Separately, PLGA was dissolved in 0.5 ml of dichloromethane (organic phase), and the internal aqueous phase was formed by adding 1% w/v Span 80 and 30 mg DH to distilled water and agitating under magnetic agitation at ambient temperature. The dichloromethane was extracted under reduced pressure after 15 min of magnetic agitation. The primary emulsion (w/o) was generated by adding organic solvent containing PLGA to the internal aqueous phase in a drop-by-drop manner using a magnetic stirrer. Subsequently, the aqueous external phase was generated by dissolving 10 ml of distilled water with PVA using a magnetic stirrer. Initially, a conventional aluminum pan was used to deposit 5 mg aliquots, which were heated from 25 to 300 °C at a scanning rate of 5 °C/min, while 25 ml/min of inert nitrogen circulated through the pan (Menshawe et al. Adult male albino rats weighing 250–30 gm and aged 3–4 months were used in the studies (Beni-Suef University Faculty of Veterinary Medicine, Lab animal). The usual lab environment has ambient temperature, humidity, and a 12-h light/dark cycle. Daily rodent food and clean water were available 24/7 from easy sources. The Nahda University Faculty of Pharmacy’s IACUC accepted this rat research with permission number NUB-011–019. All animal care, dosing, treatment, PE induction, weighing, and injections followed the protocol. Seven equal groups of six mature male Albino rats (250–300 g, 3–4 months) were formed from forty-two animals. Rats in the control negative group (CNT) (G1) received distilled water. Group two (G2) (control positive, PE, non-treated) rats received an oral Yohimbine solution at 18 mg/200 gm b.wt., corresponding to 1000 mg/kg/human, according to the capsule manufacturer’s recommendations (Clark and Stanford University Department of Physiology 1983). Each rat in G3 received Streptozotocin 50 mg/kg b.wt., I/p, for diabetic induction according to Ahmed et al. After Yohimbine-induced PE, G4 rats got standard spray on the glans penis and IN lidocaine. G5 rats received 20 µL (30 mg)/kg dapoxetine nano-preparation IN after Yohimbine-induced PE and before entering the sexually prepared female rats. Rats were given dapoxetine NPs and yohimbine in both nostrils while supine without anaesthesia. Finally, G7 rats got usual oral dapoxetine powdered not prepared. One stomach tube gavage was used daily for all treatments, dosages, and routes, including control. Experimental design for the different groups’ clearly stated in Table 2. After 8 weeks on a high-fat diet (HFD), rats received an intraperitoneal injection of STZ (2% STZ at 30 mg/kg) Sigma-Aldrich, USA, dissolved in citrate buffer with a pH of 4.5 and monitored at 4 °C. To cause diabetes, measurements of random blood glucose were taken 72 h following STZ treatment. RBG values below 16.7 mmol/L were thought to indicate diabetes in rodents. A random assessment of HFD/STZ-induced diabetic rats was performed. Height and weight fasting blood glucose (FBG) levels were measured weekly. Rats take HFD until 12 weeks, when they get ketamine and xylazine under anaesthesia. Plasma from peripheral blood from the inner canthus was centrifuged at 3000 RPM for 10 min, and glucose was tested. Sexually receptive females were prepared as method previously described by Heijkoop et al. (2018) as females induced to be in oestrus through hormonal injection of oestradiol benzoate (100 μg/ml) and progesterone (5 mg/ml) powder through a mixture of the two hormones together. For usage, heat the hormonal combination at 60 °C for 1 h and shake well. Progesterone is injected 4 h before sexual activity and oestrogen 52 h before copulation. We injected both hormones at 0.2 ml each animal. Behaviour was tested 15 min after IN injection. Male sexually trained rats were well-maintained for 30 min following female cage entrance under a dimmed red light.